CorMedix Inc reports results for the quarter ended in June - Earnings Summary

CorMedix

08/08/2023 14:31

* CorMedix Inc  CRMD.OQ  reported a quarterly adjusted loss
of 25
cents​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 24 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * CorMedix Inc's reported EPS for the quarter was a loss
of 25
cents​.
    * The mean earnings estimate of analysts had fallen by
about 16.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * CorMedix Inc shares had risen by 3.3% this quarter and
lost 3.0%
so far this year.
    * The company reported a quarterly loss of $11.27 million.
    * Wall Street's median 12-month price target for CorMedix
Inc is
$18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 8 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.24          -0.25          Missed
 Mar. 31 2023      -0.20          -0.24          Missed
 Dec. 31 2022      -0.19          -0.20          Missed
 Sep. 30 2022      -0.23          -0.17          Beat